This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3r68
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | [[ | + | ==Molecular Analysis of the PDZ3 domain of PDZK1== |
| + | <StructureSection load='3r68' size='340' side='right' caption='[[3r68]], [[Resolution|resolution]] 1.30Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[3r68]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3R68 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3R68 FirstGlance]. <br> | ||
| + | </td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene><br> | ||
| + | <tr><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3r69|3r69]], [[2d90|2d90]]</td></tr> | ||
| + | <tr><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">Cap70, Nherf3, Pdzk1 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10090 Mus musculus])</td></tr> | ||
| + | <tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3r68 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3r68 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3r68 RCSB], [http://www.ebi.ac.uk/pdbsum/3r68 PDBsum]</span></td></tr> | ||
| + | <table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | The normal expression, cell surface localization and function of the murine HDL receptor SR-BI in hepatocytes in vivo - and thus normal lipoprotein metabolism - depend on its four PDZ domain (PDZ1-PDZ4) containing cytoplasmic adaptor protein PDZK1. Previous studies showed that the C-terminus of SR-BI (target peptide) binds directly to PDZ1 and influences hepatic SR-BI protein expression. Unexpectedly an inactivating mutation in PDZ1 (20Tyr-->Ala) only partially, rather than completely, suppresses PDZK1's ability to control hepatic SR-BI. We used isothermal titration calorimetry to show that PDZ3, but not PDZ2 or PDZ4, can also bind the target peptide (Kd= 37.0 muM), albeit with ~10-fold lower affinity than PDZ1. This binding is abrogated by a 253Tyr-->Ala substitution. Comparison of the 1.5 A resolution crystal structure of PDZ3 with its bound target peptide (505QEAKL509) to that of peptide-bound PDZ1 indicated fewer target peptide stabilizing atomic interactions (hydrogen bonds and hydrophobic interactions) in PDZ3. A double [20Tyr-->Ala (PDZ1) + 253Tyr-->Ala (PDZ3)] substitution abrogated all target peptide binding to PDZK1. In vivo hepatic expression of a singly substituted (253Tyr-->Ala (PDZ3)) PDZK1 transgene (Tg) was able to correct all of the SR-BI-related defects in PDZK1 KO mice, whereas the doubly substituted [20Tyr-->Ala (PDZ1) + 253Tyr-->Ala (PDZ3)]-Tg was unable to correct these defects. Thus, we conclude that PDZK1-mediated control of hepatic SR-BI requires direct binding of SR-BI's C-terminus to either the PDZ1 or PDZ3 domain, and that binding to both domains simultaneously is not required for PDZK1 control of hepatic SR-BI. | ||
| - | + | Identification of the PDZ3 domain of the adaptor protein PDZK1 as a second, physiologically functional, binding site for the C-terminus of the HDL receptor SR-BI.,Kocher O, Birrane G, Yesilaltay A, Shechter S, Pal R, Daniels K, Krieger M J Biol Chem. 2011 May 23. PMID:21602281<ref>PMID:21602281</ref> | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | --> | + | |
| - | + | ||
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | + | </div> | |
| - | + | == References == | |
| - | + | <references/> | |
| - | + | __TOC__ | |
| - | + | </StructureSection> | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | == | + | |
| - | < | + | |
[[Category: Mus musculus]] | [[Category: Mus musculus]] | ||
[[Category: Birrane, G.]] | [[Category: Birrane, G.]] | ||
Revision as of 04:50, 5 June 2014
Molecular Analysis of the PDZ3 domain of PDZK1
| |||||||||||
